Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Depot tetracosactide[1] Tetracosactide[1] D00284 (Name: Tetracosactide (INN))[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 83
2Tetracosactide[1] Tetracosactide[1] D00284 (Name: Tetracosactide (INN))[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 83, 113, 145, 222
3Tetracosactide acetate[2] Acetate,
Tetracosactide		[1] D00284 (Name: Tetracosactide (INN))[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 83, 145
4TETRACOSACTIDE ESACETATO[1] Tetracosactide[1] D00284 (Name: Tetracosactide (INN))[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113
5TETRACOSACTIDE HEXAACETATE[1] Tetracosactide[1] D00284 (Name: Tetracosactide (INN))[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 113
6Tetracosactide hexacetaat[1] Tetracosactide[1] D00284 (Name: Tetracosactide (INN))[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 222